Francesco Draetta - Profile and Investment Details

Investor Profile

Francesco Draetta is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua, Syros Pharmaceuticals, Amunix Pharmaceuticals, Jounce Therapeutics, Hydrocision, Marea Therapeutics, Atea Pharmaceuticals, Beta Bionics, Develogen AG, eTheRNA immunotherapies, LEXEO Therapeutics, Telesta Therapeutics, Prevail Therapeutics, Nuvation BioEditas Medicine, Ardana Bioscience, Orqis Medical, XTuit Pharmaceuticals, Scorpion Therapeutics, Alpine Immune Sciences, GelSight, Dicerna Pharmaceuticals, First Wave Bio, Morphic Therapeutic, Sana Biotechnology, Adagio Therapeutics, Intarcia Therapeutics, Eurobio-Scientific, Andrew Alliance, ImpactRx, BioSilta, Ikena Oncology, ESSA Pharma, Celletra, Median Technologies, Attenua, Inc., NRG Therapeutics, Translate Bio, CropDesign, CymaBay Therapeutics, Exenta, Inc., Neurotech, Aquarius Technologies, Replimune Group, Elixir Pharmaceuticals, Checkmate Pharmaceuticals, Third Arc Bio, Imago BioSciences, Icosavax, Visterra, SpineVision, Achaogen, OnPath Technologies, Amunix, Kronos Bio, Immunic, Gossamer Bio, ARTBIO, Anaconda BioMed, Kestra Medical Technologies, Inc., Kuros Biosciences, JenaValve Technology, Trevi Therapeutics, Egalet, Paratek Pharmaceuticals, Arrakis Therapeutics, DBV Technologies, Kezar Life Sciences, Sienna Biopharmaceuticals, Oxagen, Evotec, Beam Therapeutics, Senti Biosciences, IFM Therapeutics, Chord Therapeutics, Endeavor BioMedicines, ObsEva, Arcutis Biotherapeutics, NeuroVision Imaging, . Over time, Francesco Draetta has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Francesco Draetta is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Rare Diseases, Life Science, Portfolio Management, Information Technology (IT), Finance, Biotechnology, Medical Devices, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Precision Medicine, Digital Health, Developer Tools, Travel, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Francesco Draetta, as their portfolio suggests a familiarity and interest in this area.

Understanding Francesco Draetta’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.